Le Lézard
Classified in: Health
Subjects: TDS, FVT

Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference

DUBLIN, Nov. 22, 2019 /CNW/ -- Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Bank of America Merrill Lynch Leveraged Finance Conference in Boca Raton, Florida on Tuesday, December 3, 2019 at 8:50 a.m. ET.

A live webcast and audio archive for the event will be available on the Company's website at http://investor.endo.com/events-and-presentations. Participants should allow approximately 10 minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. 

About Endo International plc

Endo International plc (NASDAQ: ENDP) is a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA. Learn more at www.endo.com.


SOURCE Endo International plc

These press releases may also interest you

at 03:00
Evive Biotech, a global biologics...

at 03:00
Judy Gaman, the CEO of Executive Medicine of Texas, was working on a pat book entitled Age to Perfection: How to Thrive to 100, Happy, Healthy, and Wise when she met Lucille Fleming. What started as an interview for the book blossomed into an...

at 02:50
Allergy Partners is pleased to announce the opening of the Allergy Partners Specialty Pharmacy located in Asheville, North Carolina. The opening of the specialty pharmacy marks the culmination of a long effort by Allergy Partners and its partner,...

at 02:47
Lipidor AB today announced an agreement with Cadila Pharmaceuticals, a leading Indian pharmaceutical company with extensive CRO capacity, to conduct a Phase III study for Lipidor's drug candidate AKP-02. The study is expected to commence in Q1 2021...

at 02:00
Telos, one of the world's most active blockchain platforms according to Blocktivity and CryptoDiffer, today announced the launch of The Epios Project, designed to facilitate anonymous testing for COVID-19 and other epidemics. Epios' flagship product...

at 02:00
APEIRON Biologics AG ("APEIRON"), a private biotechnology company specializing in the discovery, development and commercialization of novel immunotherapies for cancer and respiratory diseases, and MaxCyte, Inc., a global cell-based therapies and life...

News published on 22 november 2019 at 17:00 and distributed by: